Keywords: lundbeck, 2nd-qtr, profits, fall, danish, drug, maker
H Lundbeck' 2nd-qtr profits fall 69%
Article | 28 August 2006
Danish drug maker H Lundbeck says that its revenue for the second quarter of 2006 was 2.19 billion Danish kroner ($376.9 million), representing ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
